Host-microbe cross-talk in the lung microenvironment

Autor: Sabine Bartel, Philip M. Hansbro, Ian M. Adcock, Hermelijn H. Smits, Frank R. M. Stassen, Pieter S. Hiemstra, Robert P. Dickson, Ken R. Bracke, Reinoud Gosens, Susanne Krauss-Etschmann
Přispěvatelé: Molecular Pharmacology, Groningen Research Institute for Asthma and COPD (GRIAC), Med Microbiol, Infect Dis & Infect Prev, RS: NUTRIM - R2 - Liver and digestive health
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Pulmonary and Respiratory Medicine
Lung Diseases
medicine.medical_specialty
Respiratory Tract Diseases
Respiratory System
Gut flora
HAEMOPHILUS-INFLUENZAE
OBSTRUCTIVE PULMONARY-DISEASE
03 medical and health sciences
0302 clinical medicine
INTESTINAL MICROBIOTA
Medicine and Health Sciences
Medicine
Humans
030212 general & internal medicine
Microbiome
Intensive care medicine
Lung
11 Medical and Health Sciences
ALLERGIC AIRWAY DISEASE
Science & Technology
CYSTIC-FIBROSIS
biology
business.industry
IMMUNE-RESPONSES
Microbiota
OUTER-MEMBRANE VESICLES
Respiratory disease
GUT MICROBIOTA
Human microbiome
EPITHELIAL-CELLS
biology.organism_classification
medicine.disease
Back to Basics
Respiration Disorders
medicine.anatomical_structure
030228 respiratory system
11 Medical and Health Sciences
1116 Medical Physiology

Lung disease
RESPIRATORY MICROBIOTA
business
Life Sciences & Biomedicine
Zdroj: European Respiratory Journal, 56(2):1902320. EUROPEAN RESPIRATORY SOC JOURNALS LTD
The European Respiratory Journal
article-version (VoR) Version of Record
European Respiratory Journal, 56(2). EUROPEAN RESPIRATORY SOC JOURNALS LTD
EUROPEAN RESPIRATORY JOURNAL
European Respiratory Journal, 56(2):1902320. European Respiratory Society
ISSN: 0903-1936
1399-3003
Popis: Chronic respiratory diseases are highly prevalent worldwide and will continue to rise in the foreseeable future. Despite intensive efforts over recent decades, the development of novel and effective therapeutic approaches has been slow. However, there is new and increasing evidence that communities of micro-organisms in our body, the human microbiome, are crucially involved in the development and progression of chronic respiratory diseases. Understanding the detailed mechanisms underlying this cross-talk between host and microbiota is critical for development of microbiome- or host-targeted therapeutics and prevention strategies. Here we review and discuss the most recent knowledge on the continuous reciprocal interaction between the host and microbes in health and respiratory disease. Furthermore, we highlight promising developments in microbiome-based therapies and discuss the need to employ more holistic approaches of restoring both the pulmonary niche and the microbial community.
The reciprocal interaction between microbes and host in the lung is increasingly recognised as an important determinant of health. The complexity of this cross-talk needs to be taken into account when studying diseases and developing future new therapies. https://bit.ly/2VKYUfT
Databáze: OpenAIRE